Complex coacervation using proteins and polysaccharides enables efficient microencapsulation with high thermal stability, facilitating continuous core component release and yielding coacervates with superior properties for diverse applications. This study investigates the use of casein and pectin for microencapsulating Ocimum basilicum L. essential oil (EO) and phenolic extract (PE). Microencapsulation yield and efficiency were 85.3% and 89.8% for EO microcapsules (EO-MC) and 53.1% and 70.0% for PE microcapsules (PE-MC). Optical microscopy revealed spherical microcapsules; EO-MC had smooth surfaces, while PE-MC had porous surfaces. Thermal analysis showed stability, with both types exhibiting two stages of weight loss. XRD analysis indicated increased crystallinity in EO-MC and high crystallinity in PE-MC due to phenolic interactions. FTIR spectroscopy confirmed molecular interactions, including hydrogen bonding between phenolic compounds and the biopolymer matrix and amide bonds between the carboxyl groups of pectin and the amino groups of casein, ensuring the successful encapsulation of the bioactive compounds. These findings highlight the potential of casein and pectin for microencapsulating extracts, particularly EOs, for food industry applications.

Background: Chronic relapsing colitis involves immune dysregulation and oxidative stress, making monotherapies often insufficient. This study investigates a therapeutic strategy combining doxycycline (Dox), an immunomodulatory antibiotic, with Arthrospira platensis extracts to enhance anti-inflammatory and antioxidant effects, improving remission and controlling relapse. Methods: Ethanolic (ES) and aqueous (AS) extracts of A. platensis were chemically characterized by GC-MS after derivatization. Colitis was induced in mice using two intrarectal DNBS administrations spaced 7 days apart, with oral treatments (Dox, ES, AS, or combinations) given daily between doses. Disease progression was evaluated through clinical monitoring, histological scoring, and biochemical analysis, including MPO and CAT activities, as well as NO, MDA, and GSH levels. Results: GC-MS identified 16 bioactive compounds in each extract. ES contained mainly fatty acids and amino acids, whereas AS was rich in polysaccharides and phytol. Combined doxycycline and A. platensis extracts significantly enhanced recovery in reactivated DNBS colitis compared to monotherapies. Each treatment alone reduced disease severity, but their combination showed synergistic effects, significantly reducing disease activity index (p < 0.001), restoring mucosal integrity, and modulating inflammatory and oxidative markers (p < 0.001). Conclusion: Doxycycline potentiates the anti-colitic effects of A. platensis extracts via complementary mechanisms, offering a promising combination for managing relapsing colitis.